OUR RISING VISION
At Rise, we develop unique nanotechnology eyewear solutions. Our innovative filtering system blocks harmful sunlight wavelengths, reducing the risk of diabetes-related eye diseases – such as cataracts and retinopathy. Rise’s innovative technology can benefit the public at large, providing protection against harmful wavelengths in a wide variety of applications.
DIABETIC EYE DISEASE AND PREVENTION
Diabetes-Related
Eye Disease
Diabetes is a worldwide epidemic. An estimated 425 million adults worldwide – 629 million by 2045 – suffer from diabetes, according to the International Diabetes Federation.
Protection from Diabetic
Cataracts and Retinopathy
According to researchers from the faculty of medicine at the Technion, successful filtering of light in the 220-530 nm range and reductions in light intensity would decrease the risk of developing these conditions.
1st Generation Products
At Rise, we develop unique nanotechnology eyewear solutions. Our innovative filtering system blocks harmful sunlight wavelengths, reducing the risk of diabetes-related eye diseases – such as cataracts and retinopathy. Rise’s innovative technology can benefit the public at large, providing protection against harmful wavelengths in a wide variety of applications.
PRODUCTS
AND
INNOVATIONS
Next Generation R&D
Rise’s patented, second-generation solution uses advanced nanotechnology to effectively block harmful UV, blue light, and diabetes-spectrum wavelengths, and reduce light intensity – using transparent lenses that do not require tinting. The nanotechnology solution successfully prevents the development and progress of diabetes-related cataracts and retinopathy.
OUR NANO TECHNOLOGY PLATFORM
The Rise Nanotechnology Platform is powered by
a number of breakthrough innovation
Filtering of specific wavelengths for medical purposes
In-vivo embedding of nano particles with photochromatic characteristics
Dynamic reduction of light intensity characteristics